The Official Newsletter ofCentinel Spine®

prodisc® C Vivo & prodisc® C SK Reach 2,500th U.S. Procedure

Steve Sanderson

Centinel Spine Announces 2,500 Procedures Completed in U.S. with prodisc C Vivo & prodisc C SK Cervical Total Disc Replacement System Less than One Year After Limited Launch

Centinel Spine recently announced the completion of the 2,500th case in the U.S. with the prodisc C Vivo & prodisc C SK Cervical TDR System.

Over 350 surgeons have used the new system over the last 12 months, validating the benefits of intraoperatively selecting the ideal implant for each patient’s anatomy. Nearly 70% of the surgeon users are repeat users and the new system allows Centinel Spine to significantly accelerate competitive conversions and increase utilization within its user base. The 2,500 procedure milestone comes just five months after the 1,000th case was announced in April 2023.

According to Benjamin Geddes, MD:

“The ‘Match-the-Disc’ prodisc C Vivo & prodisc C SK system provides multiple implant options to best fit each patient’s anatomy, while at the same time not creating extra instrumentation complexity. This increases your options as a surgeon while not bogging down your staff. There have been multiple occasions where I went in thinking I would use one prodisc implant and in real time pivoted to a different prodisc implant with better fit. This was done seamlessly without wasting valuable OR time.”

- Benjamin Geddes, MD, Center for Sports Medicine & Orthopedics, Chattanooga, TN

Centinel Spine CEO Steve Murray observes:

“The prodisc C Vivo & prodisc C SK Match-the-Disc system has enabled Centinel Spine to push forward in its mission to be a catalyst of change in the spine market. Achieving this milestone so rapidly underscores surgeons’ receptivity towards the change that these new prodisc systems bring to the spine operating room, as well as expansion of the total disc replacement market.”

- Steve Murray, CEO, Centinel Spine

M
M

If you have further questions, contact:

More From Centinel Spine:
The Big Story
Centinel Spine Receives 2-Level FDA Approval for prodisc® C Vivo & prodisc® C SK Match-the-Disc™ Cervical Total Disc Replacement Devices
Read On
The Big Story
Centinel Spine® Grows prodisc® Total Disc Replacement 42% Worldwide in Third Quarter 2025 with Record EBITDA Results
Read On
Centinel Spine® Receives MDR Certification for prodisc® C Vivo & prodisc® C Nova Cervical Total Disc Replacement Systems
Read On
Centinel Spine in the News: Centinel Spine's prodisc® Revolution—Redefining Motion Preservation in 2025
Read On
Q3 2025 Medical Education Event Recap
Read On
WATCH:
Centinel Spine - CSRS Cadaveric Surgical Technique Video Featuring prodisc® C Vivo
Read On
New Surgeon Blog Post Educates on Non-Surgical Ways to Relieve Neck Pain
Read On